DexCom, Inc.
DXCM
$79.28
-$1.49-1.85%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 571.50M | 535.20M | 576.20M | 680.80M | 666.90M |
| Total Depreciation and Amortization | 252.80M | 241.90M | 234.40M | 228.90M | 221.80M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 118.40M | 96.80M | 70.10M | 67.70M | 11.20M |
| Change in Net Operating Assets | 45.00M | 90.20M | 108.80M | -155.70M | -8.50M |
| Cash from Operations | 987.70M | 964.10M | 989.50M | 821.70M | 891.40M |
| Capital Expenditure | -416.90M | -388.90M | -358.80M | -286.70M | -225.90M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 360.10M | 206.80M | 151.30M | 797.80M | 347.20M |
| Cash from Investing | -56.80M | -182.10M | -207.50M | 511.10M | 121.30M |
| Total Debt Issued | -- | -- | -- | 0.00 | 0.00 |
| Total Debt Repaid | -- | -- | -- | -136.80M | -787.30M |
| Issuance of Common Stock | 29.00M | 29.00M | 28.20M | 28.20M | 27.70M |
| Repurchase of Common Stock | -750.00M | -750.00M | -750.00M | -1.25B | -500.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -6.30M | -6.00M | -13.00M | -6.50M | -6.40M |
| Cash from Financing | -727.30M | -727.00M | -734.80M | -1.37B | -1.27B |
| Foreign Exchange rate Adjustments | 16.20M | -1.30M | -7.40M | 9.90M | -2.20M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 219.80M | 53.70M | 39.80M | -22.40M | -255.50M |